Child Health nieuws
Child Health nieuws
Professor Annelien Bredenoord and her inaugural lecture 'Can ethics save the life of biomedicine?'
Can ethics save biomedical sciences This question was posed by Annelien Bredenoord professor of Ethics in Biomedical Innovation at UMC Utrecht and Utrecht University, in her inaugural lecture. We aim for ethics that guide biomedical innovations from the inside from laboratory to society.
Read moreEU H2020 grant for unique HIT-CYSTIC FIBROSIS project
The EU has granted 6.7 M€ from the Horizon 2020 research program to a broad collaborative group of researchers, doctors, pharmaceutical companies and patient representatives. The aim is to develop ‘personalized treatments’ for Cystic Fibrosis (CF) patients with uncommon genetic profiles throughout Europe. These patients with extremely rare gene mutations can otherwise never get access to possibly life-saving treatment. Once this concept has been proven, the methodology can extend to all patients with CF and other rare genetic diseases, so that HIT-CF will impact the entire field of orphan diseases
Read moreAnnelien Bredenoord wins UU Publicity Award 2017
Professor Dr. Annelien Bredenoord, a professor of Ethics in Biomedical Innovation and tied to the Faculty of Medicine of the Utrecht University and the University Medical Center Utrecht, has won the Publicity Award 2017. Bredenoord was frequently featured in the media for, among other things, the influence medical innovations such as stem-cell research, reproductive technology, Big Data and biobanks have on patient care and society.
Read moreChild Health researcher Henk Schipper is nominated for the new scientist talent award 2016.
Child Health researcher Henk Schipper is nominated for the new scientist talent award 2016. Vote for him!
Read moreLab-grown mini-guts open door to personalised medicine
Organoid technology is changing lives by allowing a more personalised approach to medicine.
Read more